Cellcept and Provera drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Cellcept (mycophenolate mofetil) and Provera (medroxyprogesterone acetate). Common drug interactions include anxiety among females.
The phase IV clinical study analyzes what interactions people have when they take Cellcept and Provera. It is created by eHealthMe based on reports of 50 people who take the same drugs from the FDA, and is updated regularly.
What is Cellcept?
Cellcept has active ingredients of mycophenolate mofetil. It is often used in systemic lupus erythematosus. eHealthMe is studying from 41,872 Cellcept users. Check the latest studies of Cellcept.
What is Provera?
Provera has active ingredients of medroxyprogesterone acetate. It is often used in birth control. eHealthMe is studying from 54,943 Provera users. Check the latest studies of Provera.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
50 people who take Cellcept and Provera together, and have interactions are studied.

What are the common drug interactions of Cellcept and Provera, by gender? *:
female:
- Anxiety
- Pain
- Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
- Pain in extremity
- Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
- Rash pruritic (redness with itching)
- Skin hypertrophy (skin cells enlarges)
- Skin induration (an abnormally hard spot or area on the skin)
- Skin tightness
- Subcutaneous nodule
male:
n/a
What are the common drug interactions of Cellcept and Provera, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
- Anaemia (lack of blood)
- Agitation (state of anxiety or nervous excitement)
- Anxiety
- Aspartate aminotransferase increased
- Blood bilirubin increased
- Cough
- Decreased appetite
- Fatigue (feeling of tiredness)
- Febrile neutropenia (fever with reduced white blood cells)
- Hypokalaemia (low potassium)
20-29:
- Anaemia (lack of blood)
- Disease progression
- Dizziness
- Glomerulonephritis proliferative (a disorder of the glomeruli (glomerulonephritis), or small blood vessels in the kidneys)
- Haemoglobin decreased
- Leukopenia (less number of white blood cells in blood)
- Malaise (a feeling of general discomfort or uneasiness)
- Menorrhagia (an abnormally heavy bleeding and prolonged menstrual period at regular intervals)
- Pneumonitis (inflammation of the walls of the alveoli in the lungs)
- Pulmonary hypertension secondary (increase in blood pressure in the lung artery)
30-39:
- Pain
- Skin hyperpigmentation (disorders affect the colour of your skin)
- Anhedonia (inability to experience pleasure from activities usually found enjoyable)
- Anxiety
- Back pain
- Emotional distress
- Gait disturbance
- Hyperkeratosis (thickening of the outer layer of the skin)
- Joint range of motion decreased (disease of joint movement)
- Muscle fatigue (a condition in which muscles cannot exert their normal force)
40-49:
- Hypothermia (body temperature drops below the required temperature for normal metabolism and body functions)
- Hypoxia (low oxygen in tissues)
- Lethargy (tiredness)
- Malignant neoplasm progression (cancer tumour came back)
- Metabolic acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body)
- Multiple allergies (allergy to multiple agents)
- Muscle spasms (muscle contraction)
- Musculoskeletal pain (pain affects the bones, muscles, ligaments, tendons, and nerves)
- Myopathy steroid (a muscular disease in which the muscle fibres do not function due to steroid)
- Nausea (feeling of having an urge to vomit)
50-59:
- Visual field defect
- Alopecia (absence of hair from areas of the body)
- Anxiety
- Arteritis (inflammation of the walls of arteries)
- Asthma
- Blood bilirubin increased
- Breast cancer in situ
- Breast cyst
- Breast lump (localized swelling that feels different from the surrounding breast tissue)
- Breast mass
60+:
- Human herpesvirus 6 infection
- Lung infiltration (a substance that normally includes fluid, inflammatory exudates or cells that fill a region of lung)
- Pneumonia fungal
What are the existing conditions these people have? *
- High Blood Pressure: 9 people, 18.00%
- Stress And Anxiety: 8 people, 16.00%
- Anaemia (lack of blood): 7 people, 14.00%
- Wheezing (a high-pitched whistling sound made while you breath): 6 people, 12.00%
- Pain: 6 people, 12.00%
- Nuclear Magnetic Resonance Imaging Brain: 6 people, 12.00%
- Lupus Nephritis (a chronic inflammatory autoimmune disorder that may affect kidney tissue): 6 people, 12.00%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 6 people, 12.00%
- Bloody Peritoneal Effluent: 6 people, 12.00%
- Nuclear Magnetic Resonance Imaging Abdominal: 5 people, 10.00%
* Approximation only. Some reports may have incomplete information.
Do you take Cellcept and Provera?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Cellcept and Provera:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Cellcept:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Provera:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Cellcept and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Provera and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Bahall M, Reyes AJ, Ramcharan K, Hosein N, Seegobin K, Bahall K, Sharma H, Dhansingh S, Mahabir A, "Neuro-ophthalmological manifestations after intramuscular medroxyprogesterone: a forme fruste of idiopathic intracranial hypertension?", Neurology international, 2016 Sep .
- Bahall M, Reyes AJ, Ramcharan K, Hosein N, Seegobin K, Bahall K, Sharma H, Dhansingh S, Mahabir A, "Neuro-ophthalmological manifestations after intramuscular medroxyprogesterone: a forme fruste of idiopathic intracranial hypertension?", Neurology international, 2016 Sep .
How the study uses the data?
The study uses data from the FDA. It is based on mycophenolate mofetil and medroxyprogesterone acetate (the active ingredients of Cellcept and Provera, respectively), and Cellcept and Provera (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Gingivitis Aggravated and drugs of ingredients of prednisone - now
- High Blood Pressure and Hypoventilation - 6 seconds ago
- Buspirone Hydrochloride vs. Tizanidine Hydrochloride, side effect and effectiveness comparison - 10 seconds ago
- Hoarseness Or Changing Voice and drugs of ingredients of omeprazole - 12 seconds ago
- Rashes and drugs of ingredients of fluticasone propionate - 15 seconds ago
- Drug interactions of Metoclopramide and Droperidol - 20 seconds ago
- Topamax and Urinary Tract Infection for Women aged 20-29 - 26 seconds ago
- Topamax and Cystitis for Women aged 20-29 - 27 seconds ago
- Topamax and Bladder Infection for Women aged 20-29 - 27 seconds ago
- Topamax and Uti for Women aged 20-29 - 27 seconds ago